In nondiabetic pigs, chronic troglitazone treatment improved recovery of ischemic region systolic function to 44% of baseline compared to 18% in untreated controls (P<0.05).
Does troglitazone improve recovery of left ventricular function after regional ischemia in nondiabetic pigs?
Chronic troglitazone treatment improves recovery of left ventricular systolic and diastolic function after acute ischemia in nondiabetic pigs, potentially by enhancing myocardial carbohydrate oxidation.
Absolute Event Rate: 44% vs 18%
p-value: p=<0.05
BACKGROUND: This study determined whether treatment of normal (nondiabetic) pigs with the insulin-sensitizing agent troglitazone improves recovery of left ventricular (LV) function after acute ischemia and whether such effects are associated with altered myocardial substrate metabolism. METHODS AND RESULTS: Juvenile pigs (n=6) were treated with troglitazone (75 mg. kg(-1). d(-1) PO) for 8 weeks. Untreated pigs (n=8) served as controls. Under anesthetized, open-chest conditions, pigs underwent 90 minutes of moderate regional LV ischemia and 90 minutes of reperfusion. Regional LV function was assessed with subendocardial sonomicrometry crystals. Fasting plasma insulin and free fatty acid levels were lower in troglitazone-treated pigs than in untreated pigs, whereas blood glucose did not differ between groups. These findings suggest that treatment enhanced systemic insulin sensitivity. Baseline hemodynamics and regional LV function did not differ between groups. After ischemia and reperfusion, systolic function (external work) of the ischemic region recovered to 44+/-6% of baseline in troglitazone-treated pigs versus 18+/-6% of baseline in untreated pigs (P<0.05). Regional diastolic function (maximum rate of wall expansion) recovered to 78+/-7% of baseline in treated pigs versus 52+/-7% of baseline in untreated pigs (P<0.05). Recovery of global LV systolic and diastolic function was also significantly greater in treated pigs. Myocardial glucose uptake did not differ between groups under any condition; however, net myocardial lactate uptake after reperfusion was 7 times greater in troglitazone-treated pigs than in untreated pigs, suggesting that treatment enhanced myocardial carbohydrate oxidation after reperfusion. CONCLUSIONS: In nondiabetic pigs, chronic troglitazone treatment improves recovery of LV systolic and diastolic function after acute ischemia.
Zhu et al. (Tue,) conducted a other in Acute regional left ventricular ischemia (n=14). Troglitazone vs. Untreated controls was evaluated on Recovery of systolic function (external work) of the ischemic region (p=<0.05). In nondiabetic pigs, chronic troglitazone treatment improved recovery of ischemic region systolic function to 44% of baseline compared to 18% in untreated controls (P<0.05).